Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beth A Erickson

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 2, 2020
Detection of germline variants using expanded multigene panels in patients with localized pancreatic cancerAshley N Krepline, Jennifer L Geurts, Idayat Akinola, et al.
Surgery|July 6, 2019
Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgeryChad A Barnes, Mariana I Chavez, Susan Tsai, et al.
International Journal of Radiation Oncology, Biology, Physics|January 11, 2011
ACR Appropriateness Criteria® on Advanced Cervical Cancer Expert Panel on Radiation Oncology-GynecologyDavid K Gaffney, Beth A Erickson-Wittmann, Anuja Jhingran, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|August 30, 2017
Is Adjuvant Therapy Necessary for All Patients with Localized Pancreatic Cancer Who Have Received Neoadjuvant Therapy?Chad A Barnes, Ashley N Krepline, Mohammed Aldakkak, et al.
Gynecologic Oncology|December 14, 2011
ACR Appropriateness Criteria® role of adjuvant therapy in the management of early stage cervical cancerAaron H Wolfson, Mahesh A Varia, David Moore, et al.
Annals of Surgery|April 20, 2023
Biliary Adverse Events During Neoadjuvant Therapy for Pancreatic CancerSam Z Thalji, Deemantha Fernando, Kulwinder S Dua, et al.
Cancer|April 8, 2015
NRG Oncology/RTOG 0921: A phase 2 study of postoperative intensity-modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancerAkila N Viswanathan, Jennifer Moughan, Brigitte E Miller, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 13, 2017
Local Disease Control in Ocular Adnexal Lymphoproliferative Disorders: Comparative Outcomes of MALT Versus Non-MALT HistologiesBinod Dhakal, Timothy S Fenske, Sridevi Ramalingam, et al.
International Journal of Radiation Oncology, Biology, Physics|January 20, 2021
Adaptive Radiation Therapy (ART) Strategies and Technical Considerations: A State of the ART Review From NRG OncologyCarri K Glide-Hurst, Percy Lee, Adam D Yock, et al.
Frontiers in Oncology|May 1, 2020
Impact of Neoadjuvant Chemoradiation on Pathologic Response in Patients With Localized Pancreatic CancerDavid Wittmann, William A Hall, Kathleen K Christians, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 2, 2020
Detection of germline variants using expanded multigene panels in patients with localized pancreatic cancerAshley N Krepline, Jennifer L Geurts, Idayat Akinola, et al.
Surgery|July 6, 2019
Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgeryChad A Barnes, Mariana I Chavez, Susan Tsai, et al.
International Journal of Radiation Oncology, Biology, Physics|January 11, 2011
ACR Appropriateness Criteria® on Advanced Cervical Cancer Expert Panel on Radiation Oncology-GynecologyDavid K Gaffney, Beth A Erickson-Wittmann, Anuja Jhingran, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|August 30, 2017
Is Adjuvant Therapy Necessary for All Patients with Localized Pancreatic Cancer Who Have Received Neoadjuvant Therapy?Chad A Barnes, Ashley N Krepline, Mohammed Aldakkak, et al.
Gynecologic Oncology|December 14, 2011
ACR Appropriateness Criteria® role of adjuvant therapy in the management of early stage cervical cancerAaron H Wolfson, Mahesh A Varia, David Moore, et al.
Annals of Surgery|April 20, 2023
Biliary Adverse Events During Neoadjuvant Therapy for Pancreatic CancerSam Z Thalji, Deemantha Fernando, Kulwinder S Dua, et al.
Cancer|April 8, 2015
NRG Oncology/RTOG 0921: A phase 2 study of postoperative intensity-modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancerAkila N Viswanathan, Jennifer Moughan, Brigitte E Miller, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 13, 2017
Local Disease Control in Ocular Adnexal Lymphoproliferative Disorders: Comparative Outcomes of MALT Versus Non-MALT HistologiesBinod Dhakal, Timothy S Fenske, Sridevi Ramalingam, et al.
International Journal of Radiation Oncology, Biology, Physics|January 20, 2021
Adaptive Radiation Therapy (ART) Strategies and Technical Considerations: A State of the ART Review From NRG OncologyCarri K Glide-Hurst, Percy Lee, Adam D Yock, et al.
Frontiers in Oncology|May 1, 2020
Impact of Neoadjuvant Chemoradiation on Pathologic Response in Patients With Localized Pancreatic CancerDavid Wittmann, William A Hall, Kathleen K Christians, et al.
Pageof 8